Non-vitamin K antagonist oral anticoagulants may work as well as warfarin for patients with atrial fibrillation. There may be an alternative to warfarin to prevent cardiovascular problems associated with atrial fibrillation during cardioversion treatment, a new study found.That possible alternative is edoxaban, a non-vitamin K antagonist oral anticoagulant (NOAC).
